Major drugmakers, the British government and a top Alzheimer’s research charity are pooling more than $100 million to create a global fund to accelerate efforts to find a treatment or even a cure for the mind-robbing disease within a decade. The new Dementia Discovery Fund will function like a venture capital fund.

Click here to read original article